Perrigo (PRGO) Research & Development (2012 - 2026)

Perrigo's (PRGO) quarterly Research & Development came in at $24.6 million in Q1 2026, down 83.17% year-on-year from $146.2 million in Q1 2025, and up 12.84% on a QoQ basis from $21.8 million in Q4 2025.

Perrigo (PRGO) Research & Development (2012 - 2026) Analysis & Trends

Perrigo (PRGO) has 15 years of Research & Development data on file, last reported at $24.6 million in Q1 2026.

  • On a quarterly basis, Research & Development fell 83.17% year-over-year to $24.6 million in Q1 2026; TTM through Mar 2026 was $195.7 million, a 75.05% decrease from a year earlier, with the FY2025 full-year figure at $95.4 million, down 82.55% from the prior year.
  • Research & Development for Q1 2026 stood at $24.6 million, up from $21.8 million in the prior quarter.
  • Over the last five years, Research & Development for PRGO reached as high as $462.2 million in Q4 2024 and fell as low as -$366.7 million in Q4 2023.
  • Historically, Research & Development has averaged $51.5 million across 5 years, with a median of $31.5 million in 2022.
  • On a YoY basis, Research & Development climbed as much as 389.62% in 2025 and fell as far as 95.28% in 2025.
  • Year by year, Research & Development stood at -$307.9 million in 2022, then decreased by 19.1% to -$366.7 million in 2023, then surged by 226.04% to $462.2 million in 2024, then plunged by 95.28% to $21.8 million in 2025, then advanced by 12.84% to $24.6 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $24.6 million in Q1 2026, $21.8 million in Q4 2025, and $127.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 138.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 97.00 Mn
10 Perrigo 1.40 Bn 1.04 Bn 325.50 Mn 24.60 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 24.60 Mn
Dec 31, 2025 21.80 Mn
Sep 27, 2025 127.30 Mn
Jun 28, 2025 22.00 Mn
Mar 29, 2025 146.20 Mn
Dec 31, 2024 462.20 Mn
Sep 28, 2024 26.00 Mn
Jun 29, 2024 150.10 Mn
Mar 30, 2024 150.30 Mn
Dec 31, 2023 -366.70 Mn
Sep 30, 2023 150.20 Mn
Jul 1, 2023 32.20 Mn
Apr 1, 2023 31.10 Mn
Dec 31, 2022 -307.90 Mn
Oct 1, 2022 144.50 Mn
Jul 2, 2022 31.50 Mn
Apr 2, 2022 29.30 Mn
Dec 31, 2021 -283.00 Mn
Oct 2, 2021 129.70 Mn
Jul 3, 2021 139.80 Mn